Sanofi, GSK to seek approval for COVID vaccine candidate
French drugmaker Sanofi SASY.PA and its British partner GlaxoSmithKline are seeking regulatory approval for their COVID-19 vaccine to be used as a booster, as well as a standalone two-dose shot, after several setbacks